Health Rounds: Moderna combo flu/COVID vaccine succeeds in mid-stage trial

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) Feb ...
Daily Star on MSN

Huge breakthrough as scientists develop 'universal vaccine' for Covid, flu and colds

Experts at Stanford Medicine in the US have developed a universal vaccine that could be given as a nasal spray and could protect against a wide range of respiratory viruses ...

Stanford study points to vaccine that protects against multiple infections

A new Stanford study marks a big step forward in the creation of a new kind of vaccine that offers protection against a range ...
Clinical Trials Arena on MSN

Invivyd aligns with FDA advice on LIBERTY Phase III Covid-19 trial

The trial expects to enrol approximately 210 participants.
News-Medical.Net on MSN

Aptar Pharma’s intranasal solutions power CastleVax Phase II clinical trials for next-gen COVID-19 vaccine

In a significant step forward for mucosal immunity, Aptar Pharma has announced that its innovative nasal delivery systems are ...

First multi-coronavirus vaccine enters human testing, built on UW Medicine technology

A vaccine with University of Washington roots that fights a suite of coronaviruses including COVID-19 and related, deadly ...

FDA reverses course, will review Moderna’s mRNA flu vaccine candidate

The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA ...

Universal vaccine for cold, flu, COVID and allergies moves a step closer, scientists say

It is hoped that in the next few years, the vaccine could replace multiple jabs for winter respiratory infections.

US FDA reverses course, will review Moderna's flu vaccine application

By Mariam Sunny and Michael Erman Feb 18 (Reuters) - Moderna said on Wednesday the U.S. Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a ...